Harnessing The Power Of The Beacon Platform To Accelerate Antibody And Cell Therapy Development

Discover how the Beacon platform is revolutionizing the development of innovative therapies. In this informative presentation, Vikram Devgan demonstrates the platform's unparalleled capabilities for selecting, analyzing, and characterizing CD3 and CD8 double positive CAR T cells.

Learn how Beacon's high-throughput nano pen technology enables comprehensive functional analysis, including cytokine quantification and cell surface marker assessment. Witness the power of this platform in identifying distinct cellular behaviors and ensuring meticulous documentation throughout the entire process.

With over 99% monoclonality and advanced features for protein visualization and quality control, Beacon is the ideal solution for accelerating your antibody and cell therapy research. Watch now to see how Beacon can help you achieve groundbreaking results.